iron dextran (INFeD) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. The macromolecule has an apparent molecular weight of 289,000–440,000 Dalton.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$3.3148

United States

$7.0350
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

apo-ferrous gluconate | dextran iron | dextriferron | eisen-sandoz | feg iron | fergon | ferric gluconate | ferric gluconate anhydrous | ferric gluconate, sodium salt | ferric gluconate trihydrate | ferric hydroxide sucrose complex | ferric oxide saccharated | ferric oxide, saccharated | ferric saccharate | ferric sodium gluconate complex | ferri-saccharate | ferrlecit | ferrlecit 100 | ferroglucon | ferrogluconaat fna | ferroglyconicum | ferrous gluconate | ferrum verla | glucoferron | hippiron | iron dextran | iron dextran complex | iron gluconate | iron(iii) hydroxide sucrose complex | iron(iii)-hydroxide sucrose complex | iron oxide saccharated | iron oxide (saccharated) | iron saccharate | iron-saccharate | iron sucrose | iron sucrose complex | iron sugar | loesferron | losferron | low molecular weight iron dextran | polysaccharide iron complex | rulofer g | saccharated ferric oxide | saccharated iron | saccharated iron oxide | sideromal | simron | sodium ferric gluconate | sodium ferric gluconate complex | sodium ferric gluconate complex in sucrose | sodium ferrigluconate | sodium iron(iii)gluconate | sucroferric oxyhydroxide | velphoro | venofer | vitaferro brause | xi-921

Organizations (120)

Research & Development (113)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (56)

Approved Indications (3)


 

Anemia

Iron Deficiencies

Kidney Diseases (approved 2000)

Experimental Indications - Clinical Trial Phases 1-4 (56)


 

Acute Kidney Injury (Phase 2)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Aortic Valve Stenosis (Phase 4)

Arthropathy, Neurogenic (Phase 2)

Asthma (Phase 4)

Bariatric Surgery (Phase 4)

Blood Loss, Surgical (Phase 4)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 4)

Colitis, Ulcerative (Phase 3)

Colorectal Neoplasms (Phase 4)

Critical Illness (Phase 2)

Crohn Disease (Phase 3)

Delivery, Obstetric (Phase 4)

Dialysis (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Endometrial Neoplasms (Phase 4)

Fatigue (Phase 3)

Fractures, Bone (Phase 4)

Gastric Bypass (Phase 4)

General Surgery (Phase 4)

Hamartoma (Phase 4)

Healthy Volunteers (Phase 4)

Heart Diseases (Phase 1/Phase 2)

Heart Failure (Phase 4)

Hematologic Neoplasms (Phase 2/Phase 3)

Hip Fractures (Phase 4)

Hyperphosphatemia (Phase 4)

Hypertension, Pulmonary (Phase 2)

Hypoalbuminemia (Phase 4)

Infant, Premature, Diseases (Phase 2)

Inflammatory Bowel Diseases (Phase 4)

Iron Deficiencies (Phase 4)

Iron Overload (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Lymphoma (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoproliferative Disorders (Phase 3)

Malnutrition (Phase 4)

Multiple Myeloma (Phase 3)

Neoplasms (Phase 3)

Osteoarthritis (Phase 4)

Precancerous Conditions (Phase 3)

Pregnancy (Phase 2)

Pregnancy Complications (Phase 4)

Preoperative Exercise (Phase 4)

Puerperal Disorders (Phase 4)

Renal Dialysis (Phase 4)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Restless Legs Syndrome (Phase 2)

Weight Loss (Phase 3)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 116
  • # of Trial Organizations: 113

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue